You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sasanlimab

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Urothelial Carcinoma Bladder Trial in Houston (drug, radiation, procedure)

Recruiting
  • Urothelial Carcinoma Bladder
  • Sasanlimab
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Feb 15, 2022

Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

Active, not recruiting
  • Renal Cell Cancer
  • +9 more
  • PF-07263689
  • Sasanlimab
  • Duarte, California
  • +5 more
Nov 8, 2022

NSCLC Trial in Worldwide (Sasanlimab Prefilled syringe, Encorafenib, Binimetinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sasanlimab Prefilled syringe
  • +5 more
  • Duarte, California
  • +96 more
Jan 18, 2023

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Advanced Malignancies, Non-small-cell Lung Cancer Trial in Worldwide (PF-06801591)

Active, not recruiting
  • Advanced Malignancies
  • Non-small-cell Lung Cancer
  • Beijing, Beijing, China
  • +51 more
Jan 11, 2023

Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

Recruiting
  • Neoplasm Metastasis
  • Fayetteville, Arkansas
  • +33 more
Aug 20, 2022

Part 1, MELANOMA, SCCHN Trial in Worldwide (PF-06801591)

Completed
Has Results
  • Part 1
  • +8 more
  • Los Angeles, California
  • +66 more
Oct 29, 2021